Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, is undertaking a major expansion of University Hospital Quirónsalud Madrid. A new, 6,000-square-meter (almost 65,000-square-foot) wing scheduled for completion by next summer will add 52 new beds, bringing the hospital’s total to 288. The expansion will also include 25 doctors’ offices, nine resuscitation rooms and three delivery rooms, as well as two hybrid operating rooms that can be used both for conventional operations and for minimally invasive surgical procedures – so-called “keyhole surgery.” All expansion and modernization measures should be completed by the end of 2018. The total investment is about €31 million.

Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, is undertaking a major expansion of University Hospital Quirónsalud Madrid. A new, 6,000-square-meter (almost 65,000-square-foot) wing scheduled for completion by next summer will add 52 new beds, bringing the hospital’s total to 288. The expansion will also include 25 doctors’ offices, nine resuscitation rooms and three delivery rooms, as well as two hybrid operating rooms that can be used both for conventional operations and for minimally invasive surgical procedures – so-called “keyhole surgery.” All expansion and modernization measures should be completed by the end of 2018. The total investment is about €31 million.

Fresenius laid the cornerstone today for a new office building in Bad Homburg, part of the company’s headquarters expansion, at a festive ceremony attended by employees along with political and business representatives.

The building at company headquarters on Else-Kröner-Strasse is a response to the steadily increasing number of Fresenius employees. When completed in 2019, its approximately 21,500 square meters (231,000 square feet) of floor space will house some 600 modern office workplaces, conference rooms, an additional staff canteen and a parking garage.

With its “L” form, the five-story structure was designed to fit into the overall architectural concept alongside the two existing headquarters buildings, but with new interpretations of some key architectural elements. For example, the façade will include translucent panels in the distinct design colors of the four Fresenius business segments. Access to all areas of the building will be through an 800-square-meter atrium crowned by a foil-cushion roof, with all three headquarters buildings joining on to a new outdoor common area where employees can enjoy their breaks on nice days.

Stephan Sturm, CEO of Fresenius, pointed in his speech to the contribution that modern office concepts can make to optimizing cooperation among colleagues. “The cornerstone we are laying today is for a new building – but also for even better cooperation between our employees. If we want to continue growing, we will need good cooperation. We must share ideas, and learn from each other. Growth also requires flexibility, and for this reason we are creating more spaces that are modern and open-concept, which will facilitate communications and can be modified in response to changing needs.”

Mayor Alexander Hetjes cited the important role Fresenius plays in his city: “Fresenius represents the modern face of Bad Homburg as a competence center for healthcare. From its base here the company is not just one of the biggest employers in the Rhine-Main region, but is active worldwide. Fresenius, through its many activities, also helps shape life in our city. The headquarters is now undergoing a major expansion, and Bad Homburg wishes the company, and all the employees who will work in this modern building, great success and a good future in our city.”

Designed by the Wiesbaden firm BGF+ Architekten, the new building is being erected on a former parking lot and part of the land previously occupied by a high-bay warehouse. After five months of renovation and rebuilding completed in August, the modernized warehouse now takes up less space but has 60 percent more capacity thanks to the installation of new shelving technology systems.

A new five-story parking garage with space for 681 vehicles that also opened last month is another component of the expansion project, in which Fresenius is investing about €70 million. The company currently employs about 3,400 people in Bad Homburg, and an additional 300 in the nearby town of Oberursel.

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced the divestment of the business of Shiel Medical Laboratory, Inc. to Quest Diagnostics, Inc. Shiel provides comprehensive non-dialysis laboratory services in the New York-New Jersey metropolitan area.

The decision to divest Shiel is aligned with Fresenius Medical Care’s goal to further optimize the Company’s Care Coordination portfolio. Fresenius Medical Care’s dialysis-related laboratory services business, Spectra Labs, is not affected by the divestiture.

The divestment is expected to generate a modest book gain for Fresenius Medical Care. Closing of the transaction is subject to regulatory approvals and anticipated in the fourth quarter of 2017.

“The sale of Shiel Medical Laboratory will optimize the growth profile of our portfolio of Care Coordination activities in the U.S.,” said Rice Powell, Chief Executive Officer of Fresenius Medical Care. “Based on the business’ development relative to our original expectations we’re keen to focus on areas offering superior growth and benefits for our core activities. With this transaction, Shiel’s customers will have access to even more diagnostic expertise. Ensuring a smooth transition will be a priority.”

“By joining forces with Shiel, physicians and patients in the New York-New Jersey region will have broader access to Quest’s diagnostic insights and innovations,” said Steve Rusckowski, Quest Diagnostics Chairman, President and CEO. “The acquisition will also deliver on Quest's strategy to accelerate growth and drive operational excellence through strategically aligned, accretive acquisitions."

Fresenius Medical Care and Quest will also collaborate on identifying patients with early-stage chronic kidney disease, based on Quest’s laboratory data analytics, who may benefit from treatment to slow progression to end-stage renal disease (ESRD).

The price increase for hospital services in Germany has been set at 2.97% for 2018. This is in line with the level of past years.

The price increase for hospital services in Germany has been set at 2.97% for 2018. This is in line with the level of past years. 

Fresenius Medical Care has expanded its regional manufacturing plant in Bandar Enstek, Malaysia. Dato' Seri Dr. Chen Chaw Min, Secretary General of the Malaysian Ministry of Health graced the opening ceremony. The plant is a state-of-the-art facility and will be Fresenius Medical Care's regional manufacturing hub for Southeast Asia. In addition to supplying high-quality hemodialysis concentrates and disinfectants, the plant produces peritoneal dialysis (PD) products necessary for advanced continuous ambulatory PD treatment.